DocketNumber: 17-2011
Judges: Brian H. Corcoran
Filed Date: 12/30/2019
Status: Non-Precedential
Modified Date: 12/30/2019
In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 17-2011V (not to be published) LAILA SAGHIR, Chief Special Master Corcoran Petitioner, v. Filed: November 20, 2019 SECRETARY OF HEALTH AND Special Processing Unit (SPU); HUMAN SERVICES, Attorney’s Fees and Costs Respondent. Amber Diane Wilson, Maglio Christopher & Toale, PA, Washington, DC, for Petitioner. Althea Walker Davis, U.S. Department of Justice, Washington, DC, for Respondent. DECISION ON ATTORNEY’S FEES AND COSTS1 On December 21, 2017, petitioner filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,2 (the “Vaccine Act”). Petitioner alleges that she suffered adhesive capsulitis as a result of her October 26, 2016 influneza (“flu”) vaccination. (Petition at 2). On September 17, 2019, a decision was issued by then-Chief Special Master Dorsey, awarding compensation to Petitioner based on the parties’ stipulation. (ECF No. 42). Petitioner has now filed a motion for attorney’s fees and costs, dated November 6, 2019, (ECF No. 46), requesting a total award of $20,082.92 (representing $19,150.60 in 1 Because this unpublished ruling contains a reasoned explanation for the action in this case, I am required to post it on the United States Court of Federal Claims' website in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). This means the ruling will be available to anyone with access to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such material from public access. 2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012). fees and $932.32 in costs). In accordance with General Order #9, Petitioner filed a signed statement stating she incurred no out-of-pocket expenses. (ECF No. 46-3). Respondent reacted to the motion on November 8, 2019 indicating that he is satisfied that the statutory requirements for an award of attorney’s fees and costs are met in this case and defers to the Court’s discretion to determine the amount to be awarded. (ECF No. 47). On November 12, 2019, Petitioner filed a reply requesting the fees and costs be reimbursed in full. (ECF No. 48). I have reviewed the billing records submitted with Petitioner’s request. In my experience, the request appears reasonable, and I find no cause to reduce the requested hours or rates. The Vaccine Act permits an award of reasonable attorney’s fees and costs. § 15(e). Accordingly, I hereby GRANT Petitioner’s Motion for attorney’s fees and costs. I award a total of $20,082.92 (representing $19,150.60 in fees and $932.32 in costs) as a lump sum in the form of a check jointly payable to Petitioner and Petitioner’s counsel. Petitioner requests check be forwarded to Maglio Christopher & Toale, PA, 1605 Main Street, Suite 710, Sarasota Florida 34236. In the absence of a timely-filed motion for review (see Appendix B to the Rules of the Court), the Clerk shall enter judgment in accordance with this decision.3 IT IS SO ORDERED. s/Brian H. Corcoran Brian H. Corcoran Chief Special Master 3 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by filing a joint notice renouncing their right to seek review. 2